EXOZ

eXoZymes, Inc.

Price Chart

No historical data available

Latest Quote

$7.17

-0.01 (-0.10%)

Current Price

Previous Close	$7.17
Open	$7.01
Day High	$7.38
Day Low	$6.71
Volume	2,688

Fetched: 2026-08-30T04:27:42

Stock Information

Shares Outstanding	9.28M
Total Debt	$1.09M
Cash Equivalents	$5.65M
Net Income	$-10.19M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$66.53M
EPS (TTM)	$-1.20
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About eXoZymes, Inc.

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

📰 Latest News

No news articles available at the moment. Check back later for updates on EXOZ.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$9,716,471	$5,932,105	$1,796,222	$1,332,667
Other Income Expense	$88,746	$-6,842	$-200,000	-
Other Non Operating Income Expenses	$88,746	$-6,834	-	-
Net Non Operating Interest Income Expense	$363,786	$77,612	$100	$98
Total Other Finance Cost	$-363,786	$-77,612	$-100	-
Operating Expense	$9,716,471	$5,932,105	$1,796,222	$1,332,667
General And Administrative Expense	$6,009,480	$4,063,339	$1,338,811	$984,583
Other Operating Expenses	-	-	$-70,069	$-28,598
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Net Interest Income	$363,786	$77,612	$100	$98
Normalized Income	$-9,158,734	$-5,861,327	$-1,880,389	$-1,396,128
Net Income From Continuing And Discontinued Operation	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Total Operating Income As Reported	$-9,716,471	$-5,932,105	$-1,796,222	$-1,332,667
Net Income Common Stockholders	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Net Income	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Net Income Including Noncontrolling Interests	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Net Income Continuous Operations	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Pretax Income	$-9,263,939	$-5,861,335	$-1,996,122	$-1,332,569
Operating Income	$-9,716,471	$-5,932,105	$-1,796,222	$-1,332,667
Interest Income	-	-	$100	$98
Interest Income Non Operating	-	-	$100	$98
Special Income Charges	-	-	-	$0
Per Share
Diluted EPS	$-1.09	$-0.89	$-0.25	$-0.17
Basic EPS	$-1.09	$-0.89	$-0.25	$-0.17
Other
Tax Effect Of Unusual Items	$0	$0	$-42,000	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-9,428,510	$-5,664,715	$-1,399,285	$-1,184,916
Reconciled Depreciation	$287,961	$267,382	$196,937	$147,751
EBITDA (Bullshit earnings)	$-9,428,510	$-5,664,723	$-1,599,285	$-1,184,916
EBIT	$-9,716,471	$-5,932,105	$-1,796,222	$-1,332,667
Diluted Average Shares	$8,381,444	$6,563,255	$8,127,349	$8,127,349
Basic Average Shares	$8,381,444	$6,563,255	$8,127,349	$8,127,349
Diluted NI Availto Com Stockholders	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Tax Provision	$-105,205	$0	$42,267	$63,559
Research And Development	$3,706,991	$1,868,766	$527,480	$376,682
Selling General And Administration	$6,009,480	$4,063,339	$1,338,811	$984,583
Other Gand A	$2,373,724	$1,535,567	$742,637	$576,421
Salaries And Wages	$3,635,756	$2,527,772	$596,174	$408,162
Total Unusual Items	-	$-8	$-200,000	$0
Total Unusual Items Excluding Goodwill	-	$-8	$-200,000	$0
Gain On Sale Of Security	-	$-8	$-200,000	-
Other Special Charges	-	-	-	-

Fetched: 2026-08-30

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$3,397,249	$10,420,775	$-384,319	$1,372,532
Total Assets	$5,971,517	$13,034,404	$3,558,509	$2,685,658
Total Non Current Assets	$2,031,929	$2,214,022	$2,344,895	$1,216,419
Non Current Accounts Receivable	$105,205	-	-	-
Current Assets	$3,939,588	$10,820,382	$1,213,614	$1,469,239
Other Current Assets	$382,886	$363,790	$264,762	$101,137
Receivables	$517,359	$737,282	$882,319	$809,532
Other Receivables	$517,359	$737,282	$882,319	$809,532
Cash Cash Equivalents And Short Term Investments	$3,039,343	$9,719,310	$66,533	$558,570
Cash And Cash Equivalents	$3,039,343	$9,719,310	$66,533	$558,570
Cash Financial	$3,039,343	$9,719,310	$66,533	-
Debt
Total Debt	$1,243,236	$1,386,832	$1,611,819	$608,773
Long Term Debt And Capital Lease Obligation	$917,002	$1,156,805	$1,386,831	$463,770
Current Debt And Capital Lease Obligation	$326,234	$230,027	$224,988	$145,003
Liabilities
Total Liabilities Net Minority Interest	$2,574,268	$2,613,629	$3,942,828	$1,313,126
Total Non Current Liabilities Net Minority Interest	$1,007,367	$1,280,384	$1,527,534	$678,768
Non Current Deferred Liabilities	$90,365	$123,579	$140,703	$214,998
Current Liabilities	$1,566,901	$1,333,245	$2,415,294	$634,358
Payables And Accrued Expenses	$1,240,667	$1,103,218	$1,190,306	$489,355
Payables	$1,240,667	$1,103,218	$1,190,306	$489,355
Accounts Payable	$1,235,337	$924,252	$702,911	$385,796
Total Tax Payable	-	$0	$42,267	$63,559
Other Current Liabilities	-	-	$1,000,000	-
Income Tax Payable	-	-	$42,267	$63,559
Equity
Common Stock Equity	$3,397,249	$10,420,775	$-384,319	$1,372,532
Total Equity Gross Minority Interest	$3,397,249	$10,420,775	$-384,319	$1,372,532
Stockholders Equity	$3,397,249	$10,420,775	$-384,319	$1,372,532
Retained Earnings	$-21,104,692	$-11,945,958	$-6,084,623	$-4,046,234
Other
Ordinary Shares Number	$8,406,681	$8,367,810	$8,127,349	$8,127,349
Share Issued	$8,406,681	$8,367,810	$8,127,349	$8,127,349
Tangible Book Value	$3,397,249	$10,420,775	$-384,319	$1,372,532
Invested Capital	$3,397,249	$10,420,775	$-384,319	$1,372,532
Working Capital	$2,372,687	$9,487,137	$-1,201,680	$834,881
Capital Lease Obligations	$1,243,236	$1,386,832	$1,611,819	$608,773
Total Capitalization	$3,397,249	$10,420,775	$-384,319	$1,372,532
Additional Paid In Capital	$24,501,933	$22,366,725	$5,700,298	$5,418,760
Capital Stock	$8	$8	$6	$6
Common Stock	$8	$8	$6	$6
Preferred Stock	$0	$0	$0	$0
Long Term Capital Lease Obligation	$917,002	$1,156,805	$1,386,831	$463,770
Current Capital Lease Obligation	$326,234	$230,027	$224,988	$145,003
Dueto Related Parties Current	$5,330	$178,966	$445,128	$40,000
Net PPE	$1,926,724	$2,214,022	$2,344,895	$1,216,419
Accumulated Depreciation	$-1,016,662	$-728,701	$-461,319	$-264,381
Gross PPE	$2,943,386	$2,942,723	$2,806,214	$1,480,800
Leases	$328,786	$279,161	$279,161	$71,109
Other Properties	$2,560,262	$2,609,224	$2,477,215	$1,402,073
Machinery Furniture Equipment	$54,338	$54,338	$49,838	$7,618
Properties	$0	$0	$0	$0
Non Current Deferred Revenue	-	-	$140,703	$214,998

Fetched: 2026-08-30

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-6,671,957	$-8,902,101	$-1,469,582	$-1,443,079
Operating Activities
Operating Cash Flow	$-6,502,040	$-8,505,650	$-1,180,870	$-1,257,096
Cash Flow From Continuing Operating Activities	$-6,502,040	$-8,505,650	$-1,180,870	$-1,257,096
Operating Gains Losses	-	$8	$200,000	-
Investing Activities
Capital Expenditure	$-169,917	$-396,451	$-288,712	$-185,983
Investing Cash Flow	$-150,218	$-359,216	$-311,167	$-87,210
Cash Flow From Continuing Investing Activities	$-150,218	$-359,216	$-311,167	$-87,210
Net Other Investing Changes	$19,699	$37,235	$-22,455	$98,773
Financing Activities
Issuance Of Capital Stock	$0	$14,528,964	$0	$1,355,070
Financing Cash Flow	$-27,709	$18,517,643	$1,000,000	$1,355,070
Cash Flow From Continuing Financing Activities	$-27,709	$18,517,643	$1,000,000	$1,355,070
Net Common Stock Issuance	$0	$14,528,964	$0	$1,355,070
Common Stock Issuance	$0	$14,528,964	$0	$1,355,070
Net Other Financing Charges	-	$3,976,860	$1,000,000	-
Other
Repayment Of Debt	$-27,709	$0	-	-
Income Tax Paid Supplemental Data	$0	$0	$63,559	$0
End Cash Position	$3,039,343	$9,719,310	$66,533	$558,570
Beginning Cash Position	$9,719,310	$66,533	$558,570	$547,806
Changes In Cash	$-6,679,967	$9,652,777	$-492,037	$10,764
Proceeds From Stock Option Exercised	$0	$11,819	$0	-
Net Issuance Payments Of Debt	$-27,709	$0	-	-
Net Long Term Debt Issuance	$-27,709	$0	-	-
Long Term Debt Payments	$-27,709	$0	-	-
Net PPE Purchase And Sale	$-169,917	$-396,451	$-288,712	$-185,983
Purchase Of PPE	$-169,917	$-396,451	$-288,712	$-185,983
Change In Working Capital	$380,174	$-4,017,940	$220,314	$-190,072
Change In Payables And Accrued Expense	$284,552	$-4,063,949	$456,726	$222,058
Change In Payable	$284,552	$-4,063,949	$456,726	$222,058
Change In Account Payable	$311,085	$221,340	$272,890	$118,499
Change In Tax Payable	$0	$-42,267	$-21,292	$63,559
Change In Income Tax Payable	$0	$-42,267	$-21,292	$63,559
Change In Prepaid Assets	$-19,096	$-99,028	$-163,625	$-70,951
Change In Receivables	$114,718	$145,037	$-72,787	$-341,179
Other Non Cash Items	$454	$-19,404	$-41,270	$-35,150
Stock Based Compensation	$1,988,105	$1,125,639	$281,538	$216,503
Depreciation Amortization Depletion	$287,961	$267,382	$196,937	$147,751
Depreciation And Amortization	$287,961	$267,382	$196,937	$147,751
Depreciation	$287,961	$267,382	$196,937	$147,751
Net Income From Continuing Operations	$-9,158,734	$-5,861,335	$-2,038,389	$-1,396,128
Gain Loss On Investment Securities	-	$8	$200,000	-
Interest Paid Supplemental Data	-	-	$0	$0

Fetched: 2026-08-30